FDA Import Refusal AEK-4044718-5/61/1 — CIPLA LTD
The FDA refused shipment AEK-4044718-5/61/1 from CIPLA LTD (India) on Oct 17, 2023. The refused product falls under Drugs and Biologics — MEBENDAZOLE (ANTHELMINTIC). Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 17, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60WCY16 MEBENDAZOLE (ANTHELMINTIC)
- Charges
- 118,3280,75